HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CYBA
cytochrome b-245 alpha chain
Chromosome 16 Β· 16q24.2
NCBI Gene: 1535Ensembl: ENSG00000051523.12HGNC: HGNC:2577UniProt: B4DT46
354PubMed Papers
21Diseases
0Drugs
76Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Highly StudiedVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of toll-like receptor 2 signaling pathwaysuperoxide-generating NAD(P)H oxidase activityprotein bindingelectron transfer activitychronic granulomatous diseaseautoimmune polyendocrine syndrome type 1Autoimmune polyendocrinopathy type 1nerve plexus disease
✦AI Summary

CYBA encodes p22phox, a critical regulatory subunit of NADPH oxidase complexes that catalyze superoxide generation from molecular oxygen 1. The protein transfers electrons from cytosolic NADPH through flavin adenine dinucleotide and heme moieties to produce the superoxide anion (O2βˆ’), a key reactive oxygen species for microbial killing in phagocytes 1. P22phox associates with NOX1, NOX2, NOX3, and NOX4 to form functional oxidase complexes activated by phosphorylation-dependent assembly at cellular membranes 1. Loss-of-function CYBA mutations cause autosomal recessive chr16 granulomatous disease (AR22⁰CGD), characterized by severe early-childhood infections from impaired microbicidal capacity 1. Beyond immune function, CYBA polymorphisms significantly impact cardiovascular and metabolic disease risk. The C242T polymorphism shows protective effects against coronary artery disease in Asian populations and metabolic syndrome in men 23. Additionally, CYBA variants associate with diabetic nephropathy progression and end-stage renal disease in type 1 diabetes through oxidative stress mechanisms 4. CYBA genetic variants also contribute to oxidative stress in chr16 obstructive pulmonary disease 5. These findings establish CYBA as both essential for immune defense and a significant genetic modifier of oxidative stress-related diseases.

Sources cited
1
P22phox structure, NOX associations, electron transfer mechanism, NADPH oxidase activation, and role in chronic granulomatous disease
PMID: 27048830
2
C242T polymorphism shows decreased CAD risk in Asian populations; A640G polymorphism associated with reduced CAD risk
PMID: 24392120
3
C242T polymorphism T allele is protective against metabolic syndrome in men
PMID: 32406080
4
CYBA variants associate with diabetic nephropathy, ESRD, and oxidative stress markers in type 1 diabetes
PMID: 25862415
5
CYBA polymorphisms contribute to oxidative stress and COPD susceptibility
PMID: 20080081
Disease Associationsβ“˜21
chronic granulomatous diseaseOpen Targets
0.67Moderate
autoimmune polyendocrine syndrome type 1Open Targets
0.34Weak
Autoimmune polyendocrinopathy type 1Open Targets
0.34Weak
nerve plexus diseaseOpen Targets
0.20Weak
genetic disorderOpen Targets
0.19Weak
phototoxic dermatitisOpen Targets
0.16Weak
oral squamous cell carcinomaOpen Targets
0.09Suggestive
rheumatoid arthritisOpen Targets
0.08Suggestive
lung adenocarcinomaOpen Targets
0.07Suggestive
isolated agammaglobulinemiaOpen Targets
0.06Suggestive
Varicose veinsOpen Targets
0.05Suggestive
ovarian carcinomaOpen Targets
0.05Suggestive
Immunodeficiency by defective expression of HLA class 2Open Targets
0.05Suggestive
Chronic mucocutaneous candidosisOpen Targets
0.05Suggestive
immunodeficiency 51Open Targets
0.05Suggestive
Autosomal recessive hyper-IgE syndromeOpen Targets
0.05Suggestive
combined immunodeficiency due to DOCK8 deficiencyOpen Targets
0.05Suggestive
nasopharyngeal carcinomaOpen Targets
0.05Suggestive
Recurrent infection due to specific granule deficiencyOpen Targets
0.05Suggestive
breast cancerOpen Targets
0.05Suggestive
Granulomatous disease, chronic, autosomal recessive, 4UniProt
Pathogenic Variants76
NM_000101.4(CYBA):c.268C>T (p.Arg90Trp)Pathogenic
not provided|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2026β†’ Residue 90
NM_000101.4(CYBA):c.287+2T>CPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2026
NM_000101.4(CYBA):c.371C>T (p.Ala124Val)Pathogenic
not provided|Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Polyglandular autoimmune syndrome, type 1|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 124
NM_000101.4(CYBA):c.1A>G (p.Met1Val)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 1
NM_000101.4(CYBA):c.261C>A (p.Tyr87Ter)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 87
NM_000101.4(CYBA):c.58+2T>CPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025
NM_000101.4(CYBA):c.269G>A (p.Arg90Gln)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 90
NM_000101.4(CYBA):c.472_484del (p.Pro160fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 160
NM_000101.4(CYBA):c.288-1G>TPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025
NM_000101.4(CYBA):c.70G>A (p.Gly24Arg)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 24
NM_000101.4(CYBA):c.246del (p.Phe83fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|CYBA-related disorder|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 83
NM_000101.4(CYBA):c.204-2A>GPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025
NM_000101.4(CYBA):c.354C>A (p.Ser118Arg)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|not provided|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 118
NM_000101.4(CYBA):c.166dup (p.Arg56fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 56
NM_000101.4(CYBA):c.196G>T (p.Glu66Ter)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 66
NM_000101.4(CYBA):c.77del (p.Ile26fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 26
NM_000101.4(CYBA):c.58+4_58+7delPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025
NM_000101.4(CYBA):c.467dup (p.Pro157fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
β˜…β˜…β˜†β˜†2025β†’ Residue 157
NM_000101.4(CYBA):c.7C>T (p.Gln3Ter)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025β†’ Residue 3
NM_000101.4(CYBA):c.128+2T>CLikely pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2024
View on ClinVar β†—
Related Genes
NOX3Protein interaction100%NOXO1Protein interaction100%MAPK14Protein interaction100%POLDIP2Protein interaction99%NOX4Protein interaction99%DUOX1Protein interaction99%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
85%
Liver
16%
Brain
10%
Ovary
10%
Heart
7%
Gene Interaction Network
Click a node to explore
CYBANOX3NOXO1MAPK14POLDIP2NOX4DUOX1
PROTEIN STRUCTURE
Preparing viewer…
PDB7YXW Β· 2.50 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.73LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.24 [0.90–1.73]
RankingsWhere CYBA stands among ~20K protein-coding genes
  • #874of 20,598
    Most Researched354 Β· top 5%
  • #967of 5,498
    Most Pathogenic Variants76 Β· top quartile
  • #16,230of 17,882
    Most Constrained (LOEUF)1.73
Genes detectedCYBA
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Polymorphisms of C242T and A640G in CYBA gene and the risk of coronary artery disease: a meta-analysis.
PMID: 24392120
PLoS One Β· 2014
1.00
2
CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.
PMID: 27048830
Gene Β· 2016
0.90
3
[The p22phox protein and the CYBA gene. Their function and associations with atherosclerosis-related diseases].
PMID: 23905423
Wiad Lek Β· 2013
0.80
4
Structure of human phagocyte NADPH oxidase in the activated state.
PMID: 38355798
Nature Β· 2024
0.76
5
Association of
PMID: 33145364
J Immunol Res Β· 2020
0.70